© Reuters. White House trade adviser Peter Navarro listens to a news conference outside of the West Wing of the White House
By Doina Chiacu
WASHINGTON (Reuters) – White House trade adviser Peter Navarro on Monday acknowledged that members of the task force dealing with the coronavirus crisis clashed over the efficacy of the malaria drug, hydroxychloroquine, for use against the disease.
Navarro had a heated exchange on Saturday with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, Axios reported.
Fauci, the nation’s top infectious diseases expert, and other top health advisers have argued there is not enough data from the limited studies that have been done to prove the drug is effective against COVID-19, the sometimes deadly respiratory illness caused by the virus.
Navarro has been appointed by U.S. President Donald Trump to oversee the administration’s…